These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8071118)

  • 41. [Chemosensitivity test for thyroid cancer by in vitro MTT assay].
    Sasaki F; Ishimura H; Takada N; Uchino J
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1777-81. PubMed ID: 7574809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
    Cocconi G; Carlini P; Gamboni A; Gasperoni S; Rodinò C; Zironi S; Bisagni G; Porrozzi S; Cognetti F; Di Costanzo F; Canaletti R; Ruggeri EM; Camisa R; Pucci F;
    Ann Oncol; 2003 Aug; 14(8):1258-63. PubMed ID: 12881389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
    Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
    Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
    J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer].
    Yamaue H; Tanimura H
    Hum Cell; 1995 Dec; 8(4):185-8. PubMed ID: 8721089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Curative resection plus adjuvant chemotherapy for early stage primary gastric non-Hodgkin's lymphoma: a retrospective study with emphasis on prognostic factors and treatment outcome.
    Waisberg J; André EA; Franco MI; Abucham-Neto JZ; Wickbold D; Goffi FS
    Arq Gastroenterol; 2006; 43(1):30-6. PubMed ID: 16699615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.
    Macdonald JS; Fleming TR; Peterson RF; Berenberg JL; McClure S; Chapman RA; Eyre HJ; Solanki D; Cruz AB; Gagliano R
    Ann Surg Oncol; 1995 Nov; 2(6):488-94. PubMed ID: 8591078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical value of SDI test for predicting effect of postoperative chemotherapy for patients with gastric cancer.
    Baba H; Takeuchi H; Inutsuka S; Yamamoto M; Endo K; Ohno S; Maehara Y; Sugimachi K
    Semin Surg Oncol; 1994; 10(2):140-4. PubMed ID: 8052784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer.
    Cunliffe WJ
    Cancer Treat Res; 1991; 55():143-59. PubMed ID: 1681854
    [No Abstract]   [Full Text] [Related]  

  • 52. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection.
    Yamaue H; Tani M; Onishi H; Kinoshita H; Nakamori M; Yokoyama S; Iwahashi M; Uchiyama K
    Pancreas; 2002 Nov; 25(4):366-72. PubMed ID: 12409831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer.
    Ji WB; Um JW; Ryu JS; Hong KD; Kim JS; Min BW; Joung SY; Lee JH; Kim YS
    Anticancer Res; 2017 May; 37(5):2679-2682. PubMed ID: 28476844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer].
    Louvet C; de Gramont A; Demuynck B; Varette C; Lagadec B; Cady J; Krulik M
    Bull Cancer; 1991; 78(9):839-41. PubMed ID: 1751835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [High clinical predictability of histoculture drug response assay (HDRA) for drug-sensitivity of cancer of the digestive organs].
    Kubota T; Furukawa T; Kitajima M
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):461-6. PubMed ID: 8452384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of drug response in human tumors histocultured in vitro with an image-analysis MTT end point and in vivo xenografted in nude mice.
    Colangelo D; Guo HY; Connors KM; Kubota T; Silvestro L; Hoffman RM
    Anticancer Res; 1992; 12(5):1373-6. PubMed ID: 1444193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [MTT assay using fresh surgical specimens with reference to the transfer system and reproducibility in "test center" method].
    Kubota T; Suto A; Ishibiki K; Abe O; Yamada Y; Asanuma F; Kawamura E; Yamada T; Suzuki Y; Suzuki T
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2025-30. PubMed ID: 2221925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose intensity of mitomycin C in adjuvant cancer chemotherapy for patients with gastric cancer.
    Kubota T; Kumai K; Kitajima M; Fujisaki M; Yamada Y; Ushijima Y; Ishibiki K; Abe O
    J Surg Oncol; 1994 Sep; 57(1):40-5. PubMed ID: 8065152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.